Japan Tobacco (TSE:2914) Full Year 2024 Results
Key Financial Results
- Revenue: JP¥3.15t (up 11% from FY 2023).
- Net income: JP¥463.4b (down 3.9% from FY 2023).
- Profit margin: 15% (down from 17% in FY 2023). The decrease in margin was driven by higher expenses.
- EPS: JP¥261 (down from JP¥272 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Japan Tobacco EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 6.1%.
Looking ahead, revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Tobacco industry in Asia.
Performance of the market in Japan.
The company's shares are down 2.2% from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Japan Tobacco that you should be aware of.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:2914
Japan Tobacco
A tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally.
Undervalued with excellent balance sheet and pays a dividend.
Similar Companies
Market Insights
Community Narratives


